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Abstract
Invariant natural killer T (iNKT) cells are innate-like T lymphocytes that act as critical regulators
of the immune response. To better characterize this population, we profiled iNKT cell gene
expression during ontogeny and in peripheral subsets as part of the Immunological Genome
Project (ImmGen). High-resolution comparative transcriptional analyses defined developmental
and subset-specific iNKT cell gene expression programs. In addition, iNKT cells were found to
share an extensive transcriptional program with natural killer (NK) cells, similar in magnitude to
that shared with major histocompatibility complex (MHC)-restricted T cells. Strikingly, the NK-
iNKT program also operated constitutively in γδT cells and in adaptive T cells following
activation. Together, our findings highlight a core effector program regulated distinctly in innate
and adaptive lymphocytes.
Introduction
The Immunological Genome Project (ImmGen) is a consortium of immunologists and
computational biologists who aim, using rigorously standardized experimental and analysis
pipelines, to generate a high-resolution, comprehensive definition of gene expression and
regulatory networks in the mouse immune system1. In this context, we determined global
gene expression profiles for thymic and peripheral invariant natural killer T (iNKT) cell
subsets to gain insight into the iNKT cell transcriptional landscape, its unique features, and
the relationships of iNKT cells to other innate and adaptive cell lineages.
iNKT cells are a subset of αβ T cells with an semi-invariant T cell antigen receptor (TCR)
recognizing lipid antigens presented by CD1d2. By rapidly producing cytokines, these cells
modulate both the innate and adaptive arms of the immune system, critically affecting
biological processes in anti-microbial immunity, tumor rejection, and inflammation3. Like
MHC-restricted T cells, iNKT cells undergo thymic differentiation with somatic
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recombination4, recognize self and foreign antigens2,3, secrete TH1, TH 2, and TH17
cytokines5, and provide help to B cells6.
The term “NK T” was coined to reflect the expression of the natural killer (NK) cell marker
NK1.17. While a number of other NK receptors (NKRs) can also be expressed by iNKT
cells8, the validity of the term “NKT” has been called into question9 because iNKT cells are
developmentally more closely related to the T than the NK cell lineage, and because NKRs
are neither specific to iNKT cells nor expressed on all iNKT cells.
While a central role for TCR-mediated activation in iNKT cell biology is clear, striking
parallels in the behavior of both NK and iNKT cells have nevertheless emerged. The
homeostatic distribution and survival requirements of iNKT cells are similar to those of NK
cells10,11,12,13. Also comparable are their trafficking and activation kinetics. Both cell types
constitutively express inflammatory chemokine receptors, accumulate at sites of infection
within 24–72 h, and exert their effector functions without a priming requirement14,15. In
addition, evidence suggests that iNKT cells, like NK cells, can use activating NKRs to sense
stress-induced ligands15–19. iNKT cells also detect cellular stress via their TCRs, which are
reactive to inflammation-induced alterations in CD1d-presented self-lipid antigens20–22.
Finally, NK and iNKT cells engage in comparable bidirectional interactions with antigen
presenting cells (APCs) during which APC-derived inflammatory cytokines potentiate NK
and iNKT responses to surface ligands, and NK or iNKT cells, in return, promote APC
maturation23–28.
In this report, we shed light on the transcriptional programs operating over the course of
iNKT cell development and in peripheral CD4+ and CD4− iNKT cell subsets. Utilizing the
ImmGen compendium, which allows direct comparison of gene expression in developing
and mature iNKT, NK, and T cell subsets, we assess the transcriptional basis for NK- iNKT
similarities. Our data demonstrate that shared NK- iNKT transcriptional programs are more
extensive than currently appreciated and comparable in breadth to those shared by iNKT and
MHC-restricted T cells. Finally, we show that the transcriptional patterns expressed
constitutively by both NK and iNKT cells represent a core effector program also operational
in other innate lymphocytes and induced in adaptive lymphocyte populations following
activation.
Results
iNKT cell-specific developmental programs
iNKT cells, like other T lymphocytes, mature in the thymus, where they diverge from MHC-
restricted αβ T cells at the CD4+ CD8+ double-positive (DP) stage. iNKT cells subsequently
undergo sequential stages of differentiation characterized by differential expression of CD44
and NK1.14 (Supplementary Fig. 1). To characterize the developmental transcriptional
programs in iNKT cells in relation to those operating in maturing adaptive αβ T cells, we
profiled CD44− NK1.1− (stage 1), CD44+NK1.1− (stage 2) and CD44+NK1.1+ (stage 3)
thymic iNKT cells in the context of the ImmGen Project (Fig. 1a). 1850, 155 and 697 genes
were differentially expressed from DP to stage 1, stage 1 to stage 2, and stage 2 to stage 3,
respectively, using an arbitrary fold change (FC) threshold of FC > 2 (Fig. 1b, c).
Transcripts modulated between thymic iNKT cell populations included a number of genes
involved in iNKT cell maturation4 as well as several genes of unknown function
(Supplementary Tables 1–6). At the DP branch point, we identified a subset of genes
modulated selectively by stage 1 iNKT cells but not by early stage CD4+ adaptive T cells
(CD4+8int) (Fig. 1d). Although some of these genes such as Zbtb16 (PLZF) and Vdr
(vitamin D receptor) are known to play important functions in iNKT cell lineage
specification29–31, many have not yet been linked to iNKT cell development
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(Supplementary Tables 7, 8). At the last iNKT cell maturation stage, many of the most
strongly upregulated genes belonged to the killer lectin receptor family, which encodes
activating and inhibitory NK receptors (NKRs) (Fig. 1c, bottom panel). By the final stage of
ontogeny, iNKT cells expressed several NKR mRNAs at levels comparable to those of
splenic NK cells (Supplementary Fig. 2a). In addition, NKR upregulation occurs selectively
in developing iNKT cells but not in maturing MHC-restricted T cells or at any stage in early
T cell development, with a few exceptions (Fig. 1e). Flow cytometric analysis of thymic
iNKT cells confirmed the acquisition of surface NKRs over the course of maturation (Fig. 1f
and Supplementary Fig. 2b). K-means clustering analysis determined that a large number of
genes follow the same expression kinetics as NKRs over the course of the DP to stage 3
transition (Fig. 1g) suggesting that the progressive upregulation of NKRs may be part of a
broader gene program. Together, these data comprehensively characterize shared and
distinct gene expression changes occurring in maturing iNKT cells in the broader context of
αβ T cell development.
Peripheral iNKT cell transcriptional signatures
In both mouse and human, differential cytokine production has been reported between CD4+
and CD4− iNKT cells5,32,33. In addition, iNKT cell subsets from the liver have also been
suggested to be functionally distinct34. To characterize the transcriptional basis that may
underlie subset-specific functional differences, we assessed the gene expression profiles of
CD4+ and CD4− iNKT cells sorted from the spleen, liver and lungs of mice. 159 and 261
genes were differentially expressed between CD4+ and CD4− iNKT cells from the spleen or
lung, respectively, while only 17 transcripts were differentially expressed between the liver
subsets (Fig. 2a, Supplementary Fig. 3 and Supplementary Tables 9–14), suggesting that
splenic and pulmonary iNKT cell subsets may be more functionally distinct from each other
than are liver iNKT cell subsets. In all three tissues, we found that a number of NKRs were
among the most differentially expressed genes, with elevated levels in CD4− compared to
CD4+ subsets (Fig. 2a and Supplementary Fig. 3). In liver and spleen, this reflected a larger
percentage of NKR-positive cells in CD4− compared to CD4+ iNKT cells, as determined by
flow cytometry (Fig. 2b). NKR mRNA expression in peripheral iNKT cells, although
reduced compared to stage 3 thymic iNKT cells, was maintained at higher levels than most
MHC-restricted αβ T cell subsets (Fig. 2c and data not shown). In addition, comparison of
liver iNKT cell subsets to their splenic counterparts revealed that CD4− populations are
more transcriptionally similar to one another than are CD4+ iNKT cells across tissues. A
small number of genes were expressed differentially between tissues regardless of CD4
expression (Supplementary Fig. 4), supporting the idea that iNKT cells subsets may perform
organ-specific functions.
An extensive NK- iNKT shared transcriptional program
Because iNKT cells share broad functional features with NK cells, we hypothesized that
NKR expression by iNKT cells might reflect a much larger NK-NKT shared transcriptional
program than currently appreciated. To assess the extent of transcriptional relatedness
between iNKT cells and NK cells at a global level, and to compare the NK- iNKT
relationship and with that of iNKT to T cells, we calculated Euclidian distances between
subsets of steady-state NK, T and iNKT cells. Euclidian distance, a measure of the similarity
between the gene expression patterns of pairwise compared subsets, was determined using
the 15% of gene probes with the highest variability among the subsets analyzed, and is
displayed as a matrix (Fig. 3). This revealed a strong degree of similarity between mature
iNKT and NK cell gene expression (Fig. 3, top panel, area i), contrasting greater distances
observed between all MHC-restricted T cells and NK cells (Fig. 3, top panel, area ii).
Compared to the iNKT -NK cell distance, iNKT cells exhibited a somewhat closer
relationship to memory CD8+ T cells and certain memory CD4+ T cell, however, the latter
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were sorted using markers expressed at similar levels by iNKT cells (CD44+ and CD62Llow)
and likely thus themselves contain a significant percentage of iNKT cells. The average
Euclidian distance between iNKT and NK cells was only slightly larger than that separating
iNKT cells from naive CD4+ and CD8+ T cells (Fig. 3, top panel, area iii). These relative
relationships were maintained when the analysis was performed using all genes and not just
the 15% most variable (data not shown). To determine whether the NK- iNKT relationship
is dependent on the shared expression of NKRs, we recalculated the distance matrix after
removing NKRs and related molecules from the data (see on-line methods). The outcome of
the analysis remained essentially unchanged (Supplementary Fig. 5). Thus, the
transcriptional relationship between NK and iNKT cells is not limited to the shared
expression of NKRs. Together, these data support an unexpectedly substantial
transcriptional relationship between iNKT and NK cells that is close in magnitude to that
occurring between iNKT and naive T cells.
Shared and distinct iNKT cells programs
We next sought to identify the specific concordantly-regulated genes among iNKT, NK and
T cells. For this purpose, we performed one-way analysis of variance (ANOVA) comparing
the transcriptomes of peripheral steady-state iNKT cells, NK cells and naive and memory
CD4+ and CD8+ T cells. Genes with low variability over the entire ImmGen dataset were
excluded from the analysis. 20.2% (1192 genes) of the remaining genes were differentially
expressed (Bonferroni corrected P value < 0.05) between the three groups. The modulated
genes were further classified into 6 categories (see on-line methods): genes expressed
similarly in NK and iNKT cells compared to T cells (A1 or A2, higher or lower than in T
cells, respectively), genes expressed similarly in iNKT and T cells compared to NK cells (B1
or B2, higher or lower than in NK cells, respectively), and genes expressed differentially in
iNKT cells (C1 or C2, higher or lower than T and NK cells, respectively) (Fig. 4a). A
number of transcription factors, TCR signaling components, and cytokine or chemokine-
related molecules that are known to be expressed differentially by NK, iNKT, and T cells
partitioned as expected in the ANOVA categories (Fig. 4b–d). For example, the transcription
factor PLZF (Zbtb16, Fig. 4b), the chemokine receptor Cxcr6 (Fig. 4c), and a component of
the high-affinity IL-12 receptor (Il12rb1) (Fig. 4d), all known to be expressed at higher
levels in iNKT cells than in resting T or NK cells29,30,35,36, partitioned to category C1
(higher in iNKT cells relative to NK and T cells). The transcription factor T-bet (Tbx21, Fig.
4b) as well as Il12rb2 (Fig. 4d), known to be upregulated in NK and iNKT cells37,
partitioned to category A1 (higher in iNKT and NK cells relative to T cells). TCR signaling
components such as Cd3e, Itk, Plcg1, and Zap70 (Fig. 4c) segregated as anticipated to
category B1 (higher in iNKT and T compared to NK, Fig. 4c, d). Functional biological
process enrichment analysis using DAVID software38 of category A1 genes showed a
statistically significant enrichment for effector functions including NK cell-mediated
immunity, chemokine or cytokine responses, signal transduction, and cell motility (Table 1).
Distinct biological processes were also enriched in the group of genes upregulated in iNKT
cells as compared to NK and MHC-restricted T cells (category C1), and indicated a role for
these genes in proliferation and survival, likely reflecting the uniquely activated phenotype
of steady state iNKT cells (Table 2).
We found that a comparable number of genes were expressed similarly in iNKT and NK
lineages (36.91%, 440 genes, categories A1 and A2) as in iNKT and T cells (43.88%, 523
genes, categories A2 and B2). In addition, about one-fifth of the differentially expressed
genes were regulated uniquely in iNKT cells (19.21%, 229 genes, categories C1 and C2)
(Fig. 4a, Supplementary Table 15). Thus, in addition to expressing a distinctive genetic
program, iNKT cells share a transcriptional program transcriptional with steady-state NK
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cells that is extensive and similar in magnitude to that shared between iNKT cells and other
αβ T cells, consistent with the Euclidian distance analysis.
Thymic induction of NK- iNKT shared programs
To determine at what point during thymic development the transcriptional program shared
by mature iNKT and NK cells is induced, we analyzed the expression patterns of ANOVA
category A1 genes over the course of MHC-restricted T and iNKT cell differentiation by
hierarchical clustering. Although approximately 75% of the shared, upregulated NK- iNKT
gene program is expressed in early thymic precursors (ETP), these genes are then largely
shut-down or downregulated by the DP thymocyte stage, and are not reactivated in
differentiating CD4+ or CD8+ T cells. In contrast, differentiating iNKT cells upregulated
these same genes, such that stage 3 thymic iNKT cells expressed more than 90% of the
program (Fig. 5a). Consistent with this observation, the FC distribution of category A1 genes
calculated by comparing the expression of each gene in developing iNKT cells and their DP
progenitor showed an increasing shift towards higher FC values with iNKT maturation. All
three distributions were significantly different from the baseline FC distribution for all
expressed genes as determined by a Kolmogorov-Smirnov (K-S) test, with P values for
enrichment of 3.97 × 10−15, 1.28 × 10−19 and 9.14 × 10−48 for stage 1, 2 and 3 iNKT cells
respectively (Fig. 5b). In contrast, the FC distribution calculated by comparing naïve splenic
CD4+ or CD8+ T cells to DP was not significantly different between the category A1 geneset
and all expressed genes (P = 0.79 and P = 0.65, respectively). Conversely to category A1
genes, the genes that were significantly downregulated in mature NK and iNKT cells
compared to T cells (ANOVA category A2) were not as strongly elicited in differentiating
thymic iNKT cells as in CD4+ and CD8+ T cells (Supplementary Fig. 6). These data extend
our earlier observation that iNKT cells acquire NKR expression at the end of development,
and indicate that a large part of the transcriptional program iNKT cells share with NK cells
is acquired late in thymic maturation.
iNKT cell programs expressed in γδ T cells
We next asked if other lymphocytes with innate features might also express this
transcriptional program. γδ T cells can be categorized on the basis of their TCR Vγ and Vδ
chain usage. The subset bearing the Vγ2 chain tends to be IL-17 polarized, whereas the
Vγ2− subsets (including Vγ1.1+Vδ6.3+ and Vγ1.1+Vδ6.3− subsets) predominantly secrete
TH1 or TH2 cytokines39. Distinct intraepithelial lymphocyte (IEL) CD8αα+ γδ T cell
populations posses an effector phenotype similar to that of iNKT cells40,41.
In splenic γδ T cells negative for the activation marker CD44, NK- iNKT shared genes
(ANOVA category A1) were expressed at relatively low levels, similar to those observed in
resting T cells. A subset of these genes was upregulated in splenic CD44+ Vγ2+ and Vγ2−
cells. Strikingly, we found that all tissue-resident IEL γδ T cells expressed a large cluster of
category A1 genes at levels surpassing those of the reference NK and iNKT populations
(Fig. 6a). FC distributions comparing the expression of category A1 genes in splenic or IEL
γδ T cells and T cells revealed an enrichment of over-expressed genes (P value 4.67 × 10−41
and 3.90 × 10−34, respectively) (Fig. 6b). IEL γδ T cells expressed an even smaller
proportion of ANOVA category A2 genes (downregulated in NK and iNKT compared to T)
than did iNKT cells, although most of these genes were expressed in splenic γδ T cells (data
not shown). Although less prominently than for the shared NK- iNKT cell program
(category A1) a portion of the genes upregulated in iNKT cells but not T or NK subsets
(category C1) were also relatively highly expressed in γδ T cell subsets (Supplementary Fig.
7a). Together, these data suggest that most of the gene program shared by NK and iNKT
cells, as well as part of the program differentially upregulated in iNKT cells, is also utilized
by populations of γδ T cells at steady state.
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NK-iNKT shared program induction in CD8+ T cells
We next investigated the expression of the shared NK- iNKT transcriptional program in
CD8+ effector T cells, a cell population that shares functional characteristics with NK and
iNKT cells, including the expression of certain NKRs42. We examined the expression of
ANOVA categories A1 and A2 in CD8+ T cells from the spleen of ovalbumin (OVA)-
reactive αβ TCR transgenic (OT-I) mice following infection with Listeria monocytogenes
expressing OVA. Only a small fraction of ANOVA category A1 genes became upregulated
in effector CD8+ T cells at 12, 24, and 48 h following Listeria infection. By day 6, however,
the NK- iNKT shared program was dramatically upregulated, with a FC distribution
significantly enriched for higher expression, and this genetic program was maintained in
CD8+ memory T cells as late as day 100 following infection (Fig. 7a, b). In contrast, only a
limited portion of category C1 genes (differentially expressed by iNKT cells) followed a
similar pattern in effector CD8+ T cell populations (Supplementary Fig. 7b). The genes
downregulated in NK and iNKT cells compared to T cells (ANOVA category A2, which by
definition are widely expressed in naive OT-I transgenic CD8+ T cells), were partially
repressed following infection (Supplementary Fig. 8). Similar results were obtained when
the expression of the NK- iNKT shared transcriptional programs were examined in CD8+ T
cells from OT-I transgenic mice infected with OVA-expressing vesicular stomatitis virus
(VSV) (Supplementary Fig. 9). We found that the homologous human genes comprising the
NK- iNKT shared program (ANOVA category A1) were also expressed at significantly
higher levels in human peripheral blood effector memory CD8+ T cell populations as
compared to naive CD8+ T cells43 (Fig. 7c, d). Thus, a large proportion of the genetic
program shared by NK and iNKT cells is elicited in effector αβ T cells, but only several
days following their activation.
Discussion
iNKT cells do not fit the classical paradigm of adaptive T cell immunity. Indeed, innate
features are at the core their physiological functions3,14. The transcriptional basis for these
features, however, remains incompletely defined.
The transcriptional programs and regulatory factors we found to be operating during iNKT
cell maturation were consistent with previous reports, and included Zbtb16 (PLZF), Vdr,
Tbx21 (Tbet), components of the NF-κB and Ras-MapK pathways, and NKRs4,37,44,45. By
comparing developing iNKT cells to differentiating MHC-restricted T cells, we define
transcriptional programs expressed specifically by stage 1 iNKT cells shortly after the DP
branch point. We thus highlight a large number genes not previously known to affect iNKT
cell biology but likely modulating iNKT cell thymic maturation specifically.
A number of genes reported to be involved in iNKT cell development were not expressed in
an iNKT cell specific-manner. For instance, NF-κB and Ras/MapK pathway members such
as NFkb1, RelB, Ras/MapK and Egr2 were upregulated in both iNKT and non-iNKT
thymocyte populations4 (data not shown). Other genes known to affect iNKT cells
ontogeny, Bcl11b46 and the chromatin modifier Med147 for example, exhibited little or no
transcriptional variation over the course of iNKT cell differentiation. The functional
regulation of these and other genes not detected in our analyses may thus be controlled at
post-transcriptional levels.
Mature iNKT cells share several innate functional features with NK cells, developmentally
distant relatives. We hypothesized that NK and iNKT cells shared a broader transcriptional
program than is currently appreciated. Our analyses revealed that the transcriptional patterns
iNKT cells share with NK cells make up nearly as large a part of the iNKT transcriptome as
those shared with MHC-restricted T cells. Further, we found that the NK- iNKT cell shared
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program was also active in steady-state γδ T cells subsets similarly poised for rapid, innate-
like responsiveness. The NK- iNKT program can in addition be induced in adaptive αβ T
cells, but only days following antigen-specific stimulation. These data suggest that the NK-
iNKT shared program represents a core effector program operational in lymphocytes of
distinct lineages, consistent with the many functional capabilities iNKT, NK and activated
MHC-restricted T cells have in common.
The factors that regulate expression of this shared effector program remain to be fully
defined. Nevertheless, our data provides several leads. Acquired largely at the end of thymic
iNKT cell maturation, the shared program mirrors the cells’ acquisition of NKRs. NKR
expression is driven by the transcription factor T-bet both in NK and iNKT cells37. Thus, it
is likely that T-bet, which we found to be among the genes significantly upregulated in both
NK and iNKT compared to resting T cells, plays an important role in eliciting and
maintaining at least part of the shared effector lymphocyte program. T-bet-deficient iNKT
cells express reduced mRNA and protein levels of IFN-γ, granzyme B, Fas ligand, CCR5,
and CD38, all molecules that are part of the shared program44. IL-15, recently reported to
act upstream of T-bet in maturing iNKT cells45, is also likely to be involved in iNKT cell
acquisition of this program. Furthermore, IL-15 and T-bet are important for regulating CD8+
effector T cell responses48 as well as for the homeostasis of IEL γδ T cells49. Thus, IL-15
and T-bet may play an important role in inducing the expression of the shared effector
program in several cell types.
We also highlight a number of previously unappreciated transcriptional regulators exhibiting
similar expression patterns in NK and iNKT cells, and that may help regulate the core
effector program in innate lymphocytes. For example, the transcription factor Bhlhe40, a
circadian rhythm regulator50 possessing immune-modulatory functions in CD4+ T cells51,52,
as well as Smad3, a transcription factor important for tuning TGF-β-mediated lymphocyte
activation, were upregulated in both NK and iNKT cells compared to resting T cells. Also, a
number of factors were downregulated in NK and iNKT cells. Among these genes were
Lef1 and Tcf7, transcription factors downstream of the Wnt signaling pathway that are
important for the establishment and maintenance of T cell identity53. Wnt signaling, which
is typically repressed upon T cell activation54,55. The relatively low expression of Tcf7 and
Lef1 in NK and iNKT cells during development is consistent with the acquisition their
terminally differentiated effector phenotype at steady state.
Approximately 20% of the significantly differentially expressed genes between NK, iNKT,
and T cells exhibited transcriptional patterns specific to iNKT cells. As expected, PLZF
(Zbtb16) and Gata-3 were among these factors. The genes preferentially upregulated in
iNKT cells (category C1 genes) were enriched for cellular activation and survival programs.
For instance, several AP-1 family members (Jun, Junb, Jund, Fos, Fosb and Cebpb)
normally induced in cells only after activation, were expressed relatively highly in iNKT
cells. Constitutive expression of AP-1 transcription factors by iNKT cells is consistent with
their poised effector phenotype.
Together, these data offer a new view of iNKT cells and their relationships to other
lymphocyte lineages. Using the Immunological Genome consortium database, we have
uncovered gene expression programs that both link to and differentiate iNKT cells from
other innate and adaptive lymphocytes. Our data highlight extensive genetic modules that
are shared with NK cells and other innate-like T cells, and that are also elicited several days
following activation in adaptive T cells. By defining both distinct and shared transcriptional
programs in iNKT cells, our data opens avenues for future research and brings into clearer
focus how lymphocyte populations that differ markedly in their ontogeny can ultimately
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carry out similar effector functions through modular expression of similar transcriptional
programs.
Online Methods
Mice
6 week old C57BL/6 male mice shipped from Jackson Laboratories one week prior to organ
harvest were used. Mice were maintained under specific pathogen free conditions. All
studies were approved by the Animal Care and Use Committee of the Dana-Farber Cancer
Institute.
Antibodies
Anti-CD19 (MB19-1), anti-B220 (RA3–6B2), anti-Ter119 (TER119), anti-CD11b (M1/70),
anti-CD11c (N418), anti-Ly6G/Gr1 (A18), anti-CD8α (53/6.7), anti-TCRβ (H58–597), anti-
NK1.1 (PK136), anti-CD44 (IM7), anti-CD4 (GK1.5), anti-CD45 (102), anti-CD3ε (145–
2C11), anti-Ly49e,f (CM4), anti-NKG2D (CX5), anti-NKG2A (16a11), anti-2B4
(ebio244F4), and anti-CD16,32 (2.4G2) were from eBioscience. Anti-Ly49a (A1) and anti-
Ly49c,1 (5F6) were from BD biosciences. CD1d-tetramers loaded with PBS-57 (an α-
galactosylceramide analog) were provided by the NIH tetramer facility.
Cell isolation, microarray analysis and subset nomenclature
All immune cells purification were performed in strict adherence to the ImmGen standard
Operating Procedure guidelines (available at www.immgen.org). Further details on thymic,
NK cell, γδ T cell, and CD8+ T cell populations used for comparison to iNKT cells can be
found at the ImmGen website. For iNKT cells, thymocytes, splenocytes, liver and lung
mononuclear cells were isolated from 5–10 mice per sample. Thymocytes were
disaggregated, blocked with anti-CD16 and CD32 (clone 2.4G2), then stained with
fluorophore-labeled antibodies for depletion of non- iNKT cell populations, and separated
with anti-fluorophore magnetic beads (Miltenyi). Spleens were disaggregated, treated with
ACK lysis buffer (Lonza) to remove red blood cells, and then depleted of non- iNKT cells as
above. Lungs and livers were harvested after perfusion with cold PBS and mechanically
homogenized. Lungs were digested for 15 minutes at 37° C in 7 U/ml of Liberase III
enzyme (Roche) in DMEM, then filtered and washed. Livers were homogenized and liver
mononuclear cells (LMNC) were isolated by Ficoll density gradient centrifugation. iNKT
cell-enriched thymocytes, splenocytes, LMNCs and lung cells were stained for cell surface
markers (see www.immgen.org for complete staining procedure including gating strategy)
and double sorted directly into Trizol (Invitrogen) at a purity of >99%. By staining
thymocytes from CD1d-deficient mice that lack iNKT cells, a false positive rate of 2.7 ±
0.9% was estimated in the case of CD44− NK1.1− (Stage 1) iNKT cells, the rarest thymic
subset. Contamination was negligible for other iNKT cell populations. Two to four
replicates were obtained for each sample using a FACSAria, with the exception of the CD4−
iNKT subset from the lung, for which only a single replicate passed quality control (see
below). RNA extraction, microarray hybridization (Affymetrix MoGene 1.0 ST array) and
data processing were performed at the ImmGen processing center. For further details, please
see Supplementary Table 16 (subset nomenclature key), the Data Generation and Quality
Control pipeline documentation, the ImmGen Quality Control Statistics or the ImmGen
website (www.immgen.org). Non-ImmGen human and mouse datasets were downloaded
from NCBI Geo datasets43,56. Human homologs of mouse genes were determined using
NCBI HomoloGene.
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Data analysis and visualization
Data from the March 2011 ImmGen release (802 arrays with 22,268 probesets) were used.
Probesets associated with the same gene symbol were consolidated by selecting the probeset
with the highest mean expression overall. For heatmaps, data were log2-transformed and a
relative color scale with row centering (subtraction of the mean) and normalization was
used. Heatmaps were produced by using the HeatmapViewer module of GenePattern
(www.broadinstitute.org/cancer/software/genepattern/). When indicated, Pearson correlation
with pair-wise complete linkage was applied to rows for clustering analysis. Volcano plots
were produced by using the Multiplot module of GenePattern.
For K-means clustering analysis, genes were pre-filtered for mean expression value ≥ 120
(cut-off above which genes have a 95% chance of expression) and for FC>2 between any
two subsets analyzed. Clustering was performed using the ExpressCluster application (Scott
Davis, Harvard Medical School, Boston MA – application and documentation available at
http://cbdm.hms.harvard.edu) with K=10.
For Euclidian distance matrices, the 15% most variable genes were identified using the
PopulationDistances PCA application (Scott Davis), which filters probes based on a
variation of ANOVA analysis using the geometric standard deviation of populations to
weight genes that vary in multiple populations. The selected genes were log2-transformed,
filtered for probes with a mean expression value ≥ 120, and mean centered prior to
visualization. Activating and inhibitory NKRs, adaptors and signaling partners (Klra1,
Klra2, Klra3, Klra5, Klra6, Klra8, Klra9, Klra10, Klra17, Klrb1a, Klrb1b, Klrb1c, Klrb1f,
Klrc1, Klrc2, Klrc3, Klrd1, Klre1, Klri1, Klri2, Klrk1, Klrg2, Ncr1, Cd244, Fcer1g, Tyrobp
and Hcst) were present in the initial gene list used in the first analysis (Fig. 3, top panel) and
were manually removed as indicated for the second analysis (Fig. 3, bottom panel). Klra1,
Klra3, Klra5, Klra6, Klra8, Klra9, Klra10, Klrb1a, Klrb1b, Klrb1c, Klrb1f, Klrc1, Klrc2,
Klrc3, Klrd1, Klre1, Klri1, Klri2, Klrk1, Ncr1, Cd244, Fcer1g, Tyrobp (but not Klra2,
Klra17, Klrg2 or Hcst) were present after filtering for 15% most variable gene list and were
contributed to the first, but not the second Euclidian distance analysis.
For ANOVA, data were log2-transformed, low-variability genes with a standard deviation of
≤ 0.5 across all ImmGen samples were removed and only genes with expression values ≥
120 in 2 or more arrays were considered, leaving 5,900 genes. The ANOVA was performed
using the Matlab (MathWorks) function “anova1” to compare iNKT, NK and T cell
populations Bonferroni correction was applied to the resulting list of P values, and 1192
genes passed the ANOVA (p < 0.05 out of 5,900). A secondary test was used to determine
which of the three populations significantly differed from the other two, as indicated by the
“multcompare” function of Matlab. Based on the results of this analysis, the 1,192 genes
were then separated into 14 gene categories. By comparing the average expression levels in
NK, iNKT, and T cells for each gene, these categories were then sorted into 6 groups of
genes: genes expressed most similarly by NK and iNKT cells (either A1, up- or A2,
downregulated compared to T), genes expressed most similarly in T and iNKT (either B1,
up- or B2, downregulated compared to NK) and genes expressed uniquely in iNKT (either
C1, up- or C2, downregulated compared to NK and T). Functional geneset enrichment
analysis was performed using DAVID software (Version 6.7, National Institutes of Health,
National Institute for Allergy and Infectious Diseases)57. Panther biological processes38 are
shown in Tables 1 and 2. P values calculated by DAVID represent a modified Fisher Exact
test. Biological processes with P values less than 0.01 are shown.
For estimation of the significance of enrichment for the FC distributions associated with the
heatmaps in Figs. 5–7, Kolmogorov-Smirnov P values were calculated with JMP (SAS
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Institute) comparing the selected geneset to all genes meeting the criteria for expression
(>120) in the samples tested.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
iNKT cells upregulate NKRs at the end of thymic differentiation. (a) Flow cytometric
identification of thymic iNKT cells. (b) Number of genes differentially expressed during
iNKT cell developmental transitions. (c) Genes differentially expressed between DP
thymocytes and stage 1 (top), stage 1 and stage 2 (middle), and stage 2 and stage 3 iNKT
cells (bottom). Genes upregulated are highlighted in red or blue, respectively. See
Supplementary Tables 1–6 for complete lists. (d) Genes differentially expressed in stage 1
iNKT cells versus DP thymocytes. Colored highlights indicate genes differentially regulated
in iNKT but not in CD4+8int compared to DP thymocytes. See Supplementary Tables 7 and
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8 for complete lists. For b-d, only genes with expression above the detection level one or
more subsets and a coefficient of variation (CV) < 0.5 in all subsets were considered. The
differential expression threshold used was FC > 2. (e) Expression of NKRs in differentiating
thymocytes (see Supplementary Table 16 for key to subset nomenclature). Values were
log2-transformed, row centered and locally color scaled. (f) NKR surface expression as
determined by flow cytometry. Bars, mean percentage-positive ± s.e.m., n=3 mice. Data is
representative of at least two independent experiments. (g) Expression of an NKR-
containing gene cluster derived from a Euclidian distance-based K-means clustering analysis
(mean correlation, 0.958). Genes were pre-filtered for expression and for FC > 2 between
any 2 subsets, and data was log2-transformed. Klra3, 5, 6, 9, 10, Klrb1b, c, f, Klrc1, 2, 3,
Klrd1, Klri2 and Klrk1 are labeled in red.
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Fig. 2.
Expression of NKRs in peripheral CD4+ and CD4− iNKT cells. (a) Top, differential gene
expression between CD4+ and CD4iNKT cells from the spleen; bottom, differential gene
expression between CD4+ and CD4− iNKT cells from the liver. Genes up- or downregulated
with FC > 2 in CD4− compared to CD4+ subsets are highlighted in red or blue, respectively.
Only genes with expression values above the detection level in at least one subset and a CV
< 0.5 in all subsets are displayed. (b) Flow cytometric quantification of NKRs on spleen and
liver CD4+ and CD4− iNKT cells. Bars represent mean percentage-positive for surface
expression ± s.e.m., n=3 mice. Data is representative of at least two independent
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experiments. (c) NKR expression in peripheral MHC-restricted T and iNKT cell subsets.
Values were log2-transformed, gene row centered and local color scaling was used. See
Supplementary Table 16 for key to subset nomenclature.
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Fig. 3.
The global transcriptional relationship between NK and iNKT cells is similar in magnitude
to the relationship between T and iNKT cells. Euclidian distance matrix calculated using the
15% most variable probes. Only genes with mean expression values above 120 were
included in these analyses, and data was log2 transformed and mean centered. Numbers
represent average Euclidian distances between intersecting subsets. Note that the matrix is
symmetrical along the indicated diagonal. Areas of interest are marked with lowercase
Roman numerals.
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Fig. 4.
Characterization of shared and differential gene expression among iNKT, NK, and T cells.
One-way ANOVA was performed to compare gene expression in iNKT, NK, and T cell
populations. Differentially expressed genes were separated into six categories depending on
common patterns in 2 of the 3 subsets. Genes up- (A1) or down- (A2) regulated in NK and
iNKT compared to T cells; genes up- (B1) or down- (B2) regulated in iNKT and T compared
to NK cells; genes up- (C1) or down- (C2) regulated in iNKT compared to T or NK cells. (a)
Left, heatmap of genes expressed differentially in iNKT, NK, and T cells for the indicated
cell subsets, separated according to category; right, proportion of differentially expressed
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genes in each category. (b-d) Expression of ANOVA category genes in relevant manually
selected functional gene groups (see methods). Genes reported in the literature to be highly
expressed in each category shown in underlined bold. In all heatmaps, rows are mean-
centered and normalized, and local scaling is used. See Supplementary Table 16 for key to
subset nomenclature.
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Fig. 5.
Transcriptional programs shared between NK and iNKT cells are acquired during thymic
iNKT cell maturation. (a) Top, relative expression of genes significantly upregulated in
peripheral NK and iNKT cells (ANOVA category A1) over the course of thymic T and
iNKT cell maturation. Genes were ordered by hierarchical clustering using Pearson
correlation. Rows are mean-centered and normalized, and local scaling is used. Bottom,
percentages of genes exceeding the threshold for expression over the course of thymic
maturation. T cell populations are represented in the same order as in the heatmaps. (b) FC
distribution of category A1 genes in stage 1, 2 and 3 iNKT cells compared to DP thymocytes
with individual genes displayed in rank-order along the y-axis. P values represent
significance of K-S test comparing the FC distribution of the ANOVA category A1 geneset
to that of all expressed genes. See Supplementary Table 16 for key to subset nomenclature.
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Fig. 6.
Activated splenic γδ T cells and IEL γδ T cells express NK- iNKT shared gene programs.
(a) Relative expression of genes significantly upregulated in peripheral NK and iNKT
compared to T cells (ANOVA category A1) in the splenic and IEL γδ T cell subsets
indicated. Averaged values for the ANOVA subsets (iNKT, NKT and T) are displayed for
comparison. Genes are ordered by hierarchical clustering using Pearson correlation. Rows
are mean-centered, normalized and local color scaling is used. (b) ANOVA category A1
gene FC distributions for averaged splenic and IEL γδ T cell subsets compared to the
averaged T cell subset displayed with individual genes displayed in rank-order along the y-
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axis. P values represent significance of K-S test comparing the distribution of the ANOVA
category A1 geneset to that of all expressed genes. See Supplementary Table 16 for key to
subset nomenclature.
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Fig. 7.
NK-iNKT shared gene programs are induced in activated CD8+ T cells. (a) Relative
expression of genes significantly upregulated in peripheral NK and iNKT cells (ANOVA
category A1) in antigen-specific CD8+ T cells over the course of Listeria-OVA infection.
See Supplementary Table 16 for key to subset nomenclature. (b) ANOVA category A1 gene
FC distributions for activated CD8+ T cells compared to the naive control with individual
genes displayed in rank-order along the y-axis. (c) Relative expression of the human gene
homologs from ANOVA category A1 in human peripheral blood CD8+ T cell subsets from
different donors43. (d) FC distributions for human memory CD8+ T cells compared to the
Cohen et al. Page 23
Nat Immunol. Author manuscript; available in PMC 2013 September 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
naive control, using human homologs of the ANOVA category A1 geneset. For all
heatmaps, genes were ordered by hierarchical clustering using Pearson correlation. Rows are
mean-centered and normalized, and relative scaling is used. For FC distribution plots, P
values represent significance of K-S test comparing the distribution of the ANOVA category
A1 geneset to that of all expressed genes. Nve., naïve; Ctr. Mem., central memory; Eff.
Mem., effector memory.
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Table 1
Functional pathway enrichment for ANOVA category A1 genes
Biological process Genes present Fold-
enrichment
P value
BP00157:
Natural killer cell
mediated immunity
Klrc2, Klrc3, Ifng, Klrb1f,
Klrk1, Klrb1c, Klrc1 13.70 1.11 × 10
−5
BP00255:
Cytokine/chemokine
mediated immunity
Ccrl2, Ccr5, Ifng, Ccr2, Xcl1,
Ccl5 7.31 1.33 × 10
−3
BP00107:
Cytokine and
chemokine mediated
signaling pathway
Ccrl2, Il12rb2, Ccr5, Ifng,
Ccr2, Inpp5d, Xcl1, Ccl5 4.31 2.49 × 10
−3
BP00287:
Cell motility
Ccrl2, Coro2a, Dok2, Ccr5,
Ccr2, Anxa1, Abi2, Dock5,
Diap1
3.68 2.98 × 10−3
BP00148:
Immunity and defense
F2rl2, Klrc2, Klrc3, Fgr,
Cysltr2, Adora2a, Tbx21,
Klrk1, Ccl5, Ccrl2, Cd97,
Il12rb2, Ifng, Irak2, Klf6,
Il18rap, Lgals3, Gzmb,
Sh2d2a, Ccr5, Ccr2, Klrb1f,
Xcl1, Klrb1c, Klrc1, Sema4a
2.11 3.57 × 10−4
BP00102:
Signal transduction
F2rl2, Klrc2, S100a6, Gna15,
Klrc3, Fgr, Adora2a, Cysltr2,
Gpr65, Klrk1, Abi2, Itgb2,
Ccl5, Prkx, Il12rb2, Cd97,
Ccrl2, Coro2a, Zfp36l2,
Plcb3, Ifng, Rhob, Fgl2,
Rhoc, Fasl, Inpp5d, Ptprj,
Irak2, Abr, Rxra, Anxa1,
Ntng2, Smad3, Gem, Dock5,
Arhgap26, Dusp5, Dok2,
Dusp2, Ccr5, Rgs2, Rgs3,
Ccr2, Chn2, Xcl1, Sema4a,
Klrc1
1.55 6.50 × 10−4
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Table 2
Functional pathway enrichment for ANOVA category C1 genes
Biological process Genes present Fold-
enrichment
P value
BP00116:
JNK cascade
Vav3, Dusp1, Jun,
Jund, Junb, Cxcl10 14.49 5.45 × 10
−5
BP00265:
Oncogene
Fos, Vav3, Lmo4, Jun,
Jund, Etv5, Junb 10.35 5.53 × 10
−5
BP00263:
Inhibition of apoptosis
Il4, bcl2a1d, bcl2a1c,
cebpb, socs2, bcl2a1b,
bcl2a1a
8.11 2.13 × 10−4
BP00179:
Apoptosis
Il4, bcl2a1d, bcl2a1c,
cebpb, socs2, bcl2a1b,
bcl2a1a, tnfsf14, nfkbia,
gadd45b, emp1
3.25 1.88 × 10−3
BP00281:
Oncogenesis
Fos, vav3, lmo4, jun,
jund, fam129a, etv5,
junb, emp1
3.13 7.59 × 10−3
BP00111:
Intracellular signaling
cascade
Il4, cap2, vav3, socs2,
rab4a, nfkbia, junb,
cxcl10, plk3, dusp1, jun,
jund, gadd45b, tbkbp1,
dusp6, rab27a
2.78 5.12 × 10−4
BP00040:
mRNA transcription
Dtx4, cebpb, lmo4,
nfkbia, fosb, arntl,
zbtb16, rora, junb, hic1,
fos, npas2, nr1d1,
gata3, jun, jund,
dennd4c, thoc4, gfi1,
rbpj, etv5, klf4
1.76 9.97 × 10−3
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